Reference
- World Health Organization. Obesity and overweight. Fact sheet no. 311, updated January 2015. Accessed 2 February 2015 from: www.who.int/mediacentre/factsheets/fs311/en/
- Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease: The Framingham Study. J Clin Epidemiol 1991;44:183–90.
- Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565–74.
- Cagnacci A, Zanin R, Cannoletta M, et al. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. Fertil Steril 2007; 88:1603–8.
- Wing RR, Matthews KA, Kuller LH, et al. Weight gain at the time of menopause. Arch Intern Med 1991;151: 97–102.
- Gambacciani M, Ciaponi M, Cappagli B, et al. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999;2:37–44.
- Brown WJ, Williams L, Ford JH, et al. Identifying the energy gap: Magnitude and determinants of 5-year weight gain in midage women. Obes Res 2005;13:1431–41.
- Pascot A, Lemieux S, Lemieux I, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999;22:1471–8.
- Wildman RP, Sowers MR. Adiposity and the menopausal transition. Obstet Gynecol Clin North Am 2011;38:441–54.
- Cagnacci A, Arangino S, Baldassari F, et al. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 2004;48:456–62.
- Cagnacci A, Volpe A, Paoletti AM, et al. Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril 1997;68:421–5.
- Webb P. 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr 1986;44:614–19.
- Santoro N, Crawford SL, Lasley WL, et al. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab 2008;93: 1711–21.
- Cagnacci A, De Toni A, Caretto S, et al. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause 2006;13:197–201.
- Long ME, Faubion SS, Maclaughlin KL, et al. Contraception and hormonal management in the perimenopause. J Women's Health (Larchmt) 2015;24:3–10.
- Soules M, Sherman S, Parrot E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874–8.
- Lukaski HC, Johnson PE, Bolonchuck WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810–17.
- Mansell PI, Macdonald IA. Reappraisal of the Weir equation for calculation of metabolic rate. Am J Physiol 1990;27:1347–54.
- Crawford SL, Casey VA, Avis NE, McKinlay SM. A longitudinal study of weight and the menopause transition: Results from the Massachusetts Women's Health Study. Menopause 2000;7:96–104.
- Davies KM, Heaney RP, Recker RR, et al. Hormones, weight change and menopause. Int J Obes Relat Metab Disord 2001;25:874–9.
- Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 1997;82:1549–56.
- Aloia JF, Vaswani A, Russo L, et al. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995; 172:896–900.
- Ozbey N, Sencer E, Molvalilar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J 2002;49:503–9.
- Lovejoy JC, Champagne CM, De Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obesity 2008;32: 949–58.
- Hodson L, Harnden K, Banerjee R, et al. Lower resting and total energy expenditure in postmenopausal compared with premenopausal women matched for abdominal obesity. J Nutr Sci 2014;3:e3.
- Buxton CL, Atkinson WB. Hormonal factors involved in the regulation of basal body temperature during the menstrual cycle and pregnancy. J Clin Endocrinol 1948; 8:544–9.
- Halbrecht L. Ovarian function and body temperature. Lancet 1945;2:668–9.
- Cagnacci A, Tirelli A, Cannoletta M, et al. Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis. Contraception 2005;72:443–46.
- Pantoja M, Medeiros T, Baccarin MC, et al. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive. Contraception 2010;81:107–11.
- Modesto W, de Nazaré Silva Dos Santos P, Correia VM, et al. Weight variation in users of depot- medroxyprogesterone acetate, the levonorgestrel- releasing intrauterine system and a copper intrauterine device for up to ten years of use. Eur J Contracept Reprod Health Care 2014;27:1–7.
- Sitruk-Ware R. New progestogens: A review of their effects in premenopausal and postmenopausal women. Drugs Aging 2004;21:865–83.
- Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol 1982;17: 529–36.
- ESHRECapri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update 2008;14: 197–208.
- Dal’Ava N, Bahamondes L, Bahamondes MV, et al. Body weight and composition in users of levonorgestrel-releasing intrauterine system. Contraception 2012;86:350–3.
- Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013;88:503–8.